Business
ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer
Brings Significant Experience in M&A, Investor Relations, and Financial Strategy MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE
About this update from Lifeward Ltd.
[{"type":"text","content":"Brings Significant Experience in M&A, Investor Relations, and Financial Strategy\nMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Michael Lawless, CPA, as Chief Financial Officer, effective September 19, 2022. Mr. Lawless brings more than 20 years of experience leading finance and investor relations activities at life science and technology companies to drive greater financial discipline, better strategic decision making, and improved access to capital. “Mike brings an extensive background in strategic finance and investor relations for leading life science businesses and will add significant value at ReWalk as we approach key milestones and anticipated upcoming growth,” said Larry Jasinski, Chief Executive Officer. “He has a considerable track record in all aspects of the M&A process, which will be vital as we assess the acquisition of complementary businesses to supplement our organic growth. Additionally, his experience leading investor relations programs will greatly help our efforts to increase investors’ awareness of ReWalk’s opportunities, strengthen our investor base, and heighten our financial flexibility.” “I am very pleased to join ReWalk at this important and positive inflection point in the growth of the business,” said Mr. Lawless. “The expected establishment by CMS of a benefit category for reimbursement of ambulation technology could enable ReWalk to provide access to our technology for many more spinal cord injury victims. Thanks to our strong balance sheet, we are well positioned to fund this organic growth and supplement it with accretive acquisitions.” Michael Lawless Biography Mr. Lawless most recently served as a CFO consultant for Danforth Advisors, LLC, where he provided financial and analytical support services to early-stage life science companies. Prior to joining Danforth Advisors, Mr. Lawless was the CFO of Brooks Life Sciences, a $200 million division of Brooks Automation (now Azenta, Inc.). In prior roles, Mr. Lawless also served as the head of Financial Planning and Analysis for Brooks Automation and PerkinElmer, Inc., where he led all facets of planning, fore...